[January 27, 2015] |
|
Pharmatech Announces Key Hires and New Structure to Support Growth Initiative
Pharmatech
Associates has appointed Bikash Chatterjee to the
position of President and Chief Scientific Officer (CSO). Mr. Chatterjee
served as the company's Chief Technology Officer where he established
the Pharmatech Ecosystem™ as the company's design for its four distinct
consulting service offerings.
As Chief Scientific Officer, Chatterjee will be responsible for growing
the company's consulting services through its four spheres of technical
expertise: Validation, Product and Process Development, Regulatory, and
Compliance.
Pharmatech announced the following additions to their Senior Leadership
Team:
-
Wai Wong, Vice President, Validation. Mr. Wong brings 20 years
of equipment, facility and process validation experience in the
pharmaceutical, medical device, and biologic industries. Wong has
earned an international reputation for expertise in Validation having
demonstrated success in navigating the complex requirements of the
FDA, EU and PIC/s compliance. Pharmatech was founded as a
qualification and validation firm and Wong will continue to shepherd
this practice area.
Jorge Basso, Vice President of Product and Process Development.
Mr. Basso brings 23 years of process and product design experience in
the pharmaceutical, medical device, biologic and cosmetic industries,
with expert knowledge of the key components of a successful product
development program including compliance, regulatory strategy and
validation.
-
Richard Aleman, Vice President of Regulatory Compliance, a
28-year veteran of the U.S. Food and Drug Administration, brings
supervisory experience in the regulatory and enforcement arenas, with
knowledge of the compliance issues confronting the drug, biologics,
medical devices and dietary supplement industries. His international
experience includes assignments with the Food and Agricultural
Organization of the United Nations (FAO), US AID, the World Health
Organization (WHO), and the United States Pharmacopeia (USP), where he
was lead auditor.
"As we enter our third decade, Pharmatech's growth strategy centers on
our Pharmatech Ecosystem and deploying our Quality by Design and Quality
Risk Management tools on behalf of our clients," said Warren Baker,
Chief Executive Officer. "Today, with engagements in the biotech arena,
our work depends on understanding our client's scientific foundations.
Bikash's contributions as Chief Scientific Officer will set new higher
standards for our work as best-in-class service providers with a mission
of compliance through science."
"Pharmatech's ecosystem is based on expert knowledge in all four
practice areas at the leadership team level. Our team is exceptional in
their knowledge of their specific practice areas and in the breadth and
depth of experience in the life sciences," said Bikash Chatterjee. "To
remain competitive requires a complex mix of technical knowledge,
practical business experience and broad regulatory compliance
understanding, wrapped up in a culture of precise execution. That has
been our recipe for success since 1995 and, as we enter our 20th
year of business, it is the foundation for our future success."
About Pharmatech Associates
Pharmatech Associates provides consulting and services to the regulated
life science industry. Pharmatech's services cover four spheres of
technical expertise that are necessary throughout the complete product
development lifecycle: Product and Process Development, Compliance,
Regulatory, and Validation. This interconnected framework of services
denotes the Pharmatech EcosystemTM. Pharmatech advises
clients that range in size from startups to large multi-national
corporations on projects in Asia, Europe and North America from its
headquarters in the San Francisco Bay Area.
[ Back To TMCnet.com's Homepage ]
|